Literature DB >> 30843469

Serum Neurofilament Light Is Elevated Differentially in Older Adults with Uncomplicated Mild Traumatic Brain Injuries.

Grant L Iverson1, Preethi J Reddi2, Jussi P Posti3,4, Anna-Kerttu Kotilainen5, Olli Tenovuo4, Juha Öhman6, Henrik Zetterberg7,8,9,10, Kaj Blennow7,8, Teemu M Luoto6.   

Abstract

Neurofilament light (NF-L) might have diagnostic and prognostic potential as a blood biomarker for mild traumatic brain injury (mTBI). However, elevated NF-L is associated with several neurological disorders associated with older age, which could confound its usefulness as a traumatic brain injury biomarker. We examined whether NF-L is elevated differentially following uncomplicated mTBI in older adults with pre-injury neurological disorders. In a case-control study, a sample of 118 adults (mean age = 62.3 years, standard deviation [SD] = 22.5, range = 18-100; 52.5% women) presenting to the emergency department (ED) with an uncomplicated mTBI were enrolled. All participants underwent head computed tomography in the ED and showed no macroscopic evidence of injury. The mean time between injury and blood sampling was 8.3 h (median [Md] = 3.5; SD = 13.5; interquartile range [IQR] = 1.9-6.0, range = 0.8-67.4, and 90% collected within 19 h). A sample of 40 orthopedically-injured trauma control subjects recruited from a second ED also were examined. Serum NF-L levels were measured and analyzed using Human Neurology 4-Plex A assay on a HD-1 Single Molecule Array (Simoa) instrument. A high correlation was found between age and NF-L levels in the total mTBI sample (r = 0.80), within the subgroups without pre-injury neurological diseases (r = 0.76) and with pre-injury neurological diseases (r = 0.68), and in the trauma control subjects (r = 0.76). Those with mTBIs and pre-injury neurological conditions had higher NF-L levels than those with no pre-injury neurological conditions (p < 0.001, Cohen's d = 1.01). Older age and pre-injury neurological diseases are associated with elevated serum NF-L levels in patients with head trauma and in orthopedically-injured control subjects.

Entities:  

Keywords:  aging; biomarker; blood; neurofilament; traumatic brain injury

Mesh:

Substances:

Year:  2019        PMID: 30843469     DOI: 10.1089/neu.2018.6341

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  9 in total

Review 1.  Neurofilaments in disease: what do we know?

Authors:  Brian A Gordon
Journal:  Curr Opin Neurobiol       Date:  2020-03-06       Impact factor: 6.627

2.  Use of high-sensitivity digital ELISA improves the diagnostic performance of circulating brain-specific proteins for detection of traumatic brain injury during triage.

Authors:  Grant C O'Connell; Megan L Alder; Christine G Smothers; Carolyn H Still; Allison R Webel; Shirley M Moore
Journal:  Neurol Res       Date:  2020-02-12       Impact factor: 2.448

3.  Human plasma biomarker responses to inhalational general anaesthesia without surgery.

Authors:  Stacie Deiner; Mark G Baxter; Joshua S Mincer; Mary Sano; James Hall; Ismail Mohammed; Sid O'Bryant; Henrik Zetterberg; Kaj Blennow; Roderic Eckenhoff
Journal:  Br J Anaesth       Date:  2020-06-11       Impact factor: 9.166

4.  From biomechanics to pathology: predicting axonal injury from patterns of strain after traumatic brain injury.

Authors:  Cornelius K Donat; Maria Yanez Lopez; Magdalena Sastre; Nicoleta Baxan; Marc Goldfinger; Reneira Seeamber; Franziska Müller; Polly Davies; Peter Hellyer; Petros Siegkas; Steve Gentleman; David J Sharp; Mazdak Ghajari
Journal:  Brain       Date:  2021-02-12       Impact factor: 13.501

5.  Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.

Authors:  Pashtun Shahim; Adam Politis; Andre van der Merwe; Brian Moore; Vindhya Ekanayake; Sara M Lippa; Yi-Yu Chou; Dzung L Pham; John A Butman; Ramon Diaz-Arrastia; Henrik Zetterberg; Kaj Blennow; Jessica M Gill; David L Brody; Leighton Chan
Journal:  Neurology       Date:  2020-07-08       Impact factor: 9.910

6.  Neurofilament light as a biomarker in traumatic brain injury.

Authors:  Pashtun Shahim; Adam Politis; Andre van der Merwe; Brian Moore; Yi-Yu Chou; Dzung L Pham; John A Butman; Ramon Diaz-Arrastia; Jessica M Gill; David L Brody; Henrik Zetterberg; Kaj Blennow; Leighton Chan
Journal:  Neurology       Date:  2020-07-08       Impact factor: 9.910

7.  A population-based study of head injury, cognitive function and pathological markers.

Authors:  Jonathan M Schott; Marcus Richards; Nick C Fox; Sarah-Naomi James; Jennifer M Nicholas; Christopher A Lane; Thomas D Parker; Kirsty Lu; Ashvini Keshavan; Sarah M Buchanan; Sarah E Keuss; Heidi Murray-Smith; Andrew Wong; David M Cash; Ian B Malone; Josephine Barnes; Carole H Sudre; William Coath; Lloyd Prosser; Sebastien Ourselin; Marc Modat; David L Thomas; Jorge Cardoso; Amanda Heslegrave; Henrik Zetterberg; Sebastian J Crutch
Journal:  Ann Clin Transl Neurol       Date:  2021-03-11       Impact factor: 5.430

Review 8.  Electrochemical sensing of blood proteins for mild traumatic brain injury (mTBI) diagnostics and prognostics: towards a point-of-care application.

Authors:  Nadezda Pankratova; Milica Jović; Marc E Pfeifer
Journal:  RSC Adv       Date:  2021-05-12       Impact factor: 4.036

9.  Neurofilament light chain level in traumatic brain injury: A system review and meta-analysis.

Authors:  Wenyan Gao; Zhongshan Zhang; Xiaoling Lv; Qing Wu; Jing Yan; Genxiang Mao; Wenmin Xing
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.